CCR2 and glomerulonephritis: Additionally, further evaluation using other QC/isoQC inhibitors with better in vitro and in vivo profiles will tell maximum efficacy of inhibition of CCL2/CCR2 axis in the studied glomerulonephritis model, while the present study showed partial inhibitory effects of PQ529 on systemic and local CCL2 levels.